Return to Results

Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema

new search

Trial Conditions
  • Pulmonary Emphysema
What is the purpose of this trial?

The purpose of this study is to determine whether the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System is safe in patients with advanced emphysema.

Date & Status

Completed

Who can Participate?

Eligibility

Ages:
18 and older

Gender:
Both

Eligibility

Inclusion Criteria:

- Advanced emphysema

- Limited exercise capacity and persistent symptoms despite medical therapy

- Age between 18 and 75

- No significant heart, kidney or liver disease

- Willingness and ability to tolerate bronchoscopy

- No prior Lung Volume Reduction Surgery or Lung Transplantation

- Screening test results indicating that the procedure is appropriate

Gender: Both
Steward Physician(s)
  • John J. Reilly, MD
Facilities
  • St. Elizabeth's Medical Center - Completed
Trial Interventions
Biological
  • BLVR
Physician Researcher

Investigator Name:

  • John J. Reilly, MD

Other Information

Sponsor: Aeris Therapeutics
Phase: Phase 1
Trial ID: NCT00085852
Volunteers:  Not Accepting Healthy Volunteers

new search

Connect with Steward

Visit Our Twitter Feed Visit Our Facebook Page Email This Page Print This Page

Subscribe to our patient e-newsletter

Copyright © 2014 Steward Health Care
Connect Healthcare Panacea CMS Solutions